BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Medegen Inc. Expands, Opens New Facility in Mexico


1/15/2008 9:26:12 AM

Increase in Capacity to Meet Heightened Demand for Medical Product Manufacturing Services for Pharmaceutical and Medical Device Companies

ONTARIO, Calif.--(BUSINESS WIRE)--Medegen Inc., a leading provider of medical devices, components and manufacturing services to the healthcare industry, today announced it has expanded its manufacturing capabilities into Tijuana, Mexico. The recently opened facility will enable Medegen, through its Manufacturing Services operating unit, to meet the heightened demand for outsourced contract manufacturing as the medical device market is forecasted to grow at an annual rate of 10%.

Contract manufacturing, whereby medical device companies outsource the manufacturing of their products to partners like Medegen, is expected to reach the $8 billion mark industry-wide by year end.

“Expansion of our manufacturing facilities will provide medical device companies with high-quality and cost-effective outsourcing solutions,” said Jeff Goble, President of Medegen. “This marks a new milestone for Medegen as we focus on growing our medical manufacturing services business unit, while continuing to develop innovative Maximus brand technologies for the intravenous medication delivery market.”

The new 42,000-square-foot facility will enhance contract manufacturing capabilities to the medical device and pharmaceutical industries significantly expanding the services of Medegen’s Manufacturing Services operating unit.

The facility will also handle Medegen’s finished goods assembly for its Maximus brand of IV therapy products that feature Tru-Swab™ valve technology.

“Coupling Ontario-based medical device development resources with the device assembly capabilities of the Tijuana operation allows Medegen to offer a comprehensive range of manufacturing services,” said Ross Magladry, Medegen’s Vice President of Business Development, Manufacturing Services. “This expansion provides the market a one-stop alternative encompassing a scope of services from product design through sterile device distribution.”

The brand new, FDA-registered manufacturing plant features state-of-the-art clean rooms and is FDA QSR compliant and ISO 13485 certified. The facility is conveniently located within a mile of the Otay Mesa crossing in the Parque Industrial Chilpancingo in Tijuana, Mexico.

For a view of available hi-res photos, visit: http://www.flickr.com/photos/medegen.

About Medegen Inc.

Medegen is a leading innovator in infusion therapy, focused on helping hospitals drive greater clinical performance for improved patient care. The growing company provides clinically superior medical products and reliable, cost-effective manufacturing services to the medical community through its three operating units: Manufacturing Services, Maximus and KippMed. Manufacturing Services provides cost-effective contract manufacturing solutions to medical device and pharmaceutical companies. KippMed manufactures and markets IV therapy components for the OEM market, drawing from a 25-year history in IV component supply. Maximus develops, manufactures and markets needleless intravenous therapy products for the acute care market. The Maximus line of medical products feature patent-protected technologies which improve patient outcomes and greatly reduce bloodstream infection rates. Medegen is headquartered in Ontario, Calif., with executive offices in Scottsdale, Ariz. and operations in Tijuana, Mexico. For more, visit http://www.medegen.com/.

Contact: Sacks PR Kathy Sacks, 602-619-4444 kathy@sackspr.com

Source: Medegen Inc.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->